Search
for
Sort by
Research 181–210 of 1000+
- The expression of equine keratins K42 and K124 is restricted to the hoof epidermal lamellae of Equus caballus
- The multipotency of adult vibrissa follicle stem cells
- Alopecia areata after mogamulizumab treatment
- Biochemical examination of fetal skin biopsy specimens obtained by fetoscopy: Use of the method for analysis of keratins and filaggrin
- A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
- Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
- Cutaneous lesions and clinical outcomes in five cats after frunevetmab injections
- Preparation of a highly specific single chain variable fragment antibody targeting miroestrol and its application in quality control of <i>Pueraria candollei</i> by enzyme‐linked immunosorbent assay
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- Hypertrichosis of the pinnae in a patient using panitumumab
- Drug-induced alopecia areata: A systematic review
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- Microneedles as a perspective for transdermal therapeutic systems
- Drug-induced scarring and permanent alopecia
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Platelet Immune Interactions, Lifespan, and Senescence
- NF-κB in biology and targeted therapy: new insights and translational implications
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor
- Hair Growth in a Patient with Alopecia Areata on Tocilizumab
- Severe scarring alopecia associated with combinational use of ficlatuzumab and gefitinib: a clinical and immunohistochemistry study
- X-linked Recessive Ectodysplasin A Mutations Induced Hypohidrotic Ectodermal Dysplasia and Severe Atopic Dermatitis Successfully Treated with Dupilumab
- Editorial: Prevention and treatment of skin diseases
- A case of dupilumab-induced psoriatic alopecia
- Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis
- BI35 A case of dupilumab-induced scalp psoriasis and review of the literature